Human samples used in this study were part of the samples collected randomly during a countrywide arbovirus surveillance study conducted under the International Cooperation on Key Technologies of Biosafety along the China-Pakistan economic corridor. Due to limited availability of resources, troublesome geopolitical status, and difficulty in convincing farmers to provide samples, convenience sampling was performed. Because seroprevalence of the disease under study was unknown in these areas of Pakistan, the sample size was calculated by considering the expected prevalence to be 50% with confidence limits of 95% and desired absolute precision of 5% to take maximum numbers of samples (1). We collected a total of 1,872 human serum samples during 2017-2018. We also recorded information on individual factors such as demographics, animal ownership, and education status. In total, we collected 930 (49.68%) samples from Punjab, 567 (30.29%) from Sindh, 247 (13.19%) from Balochistan, and 128 (6.84%) from Khyber Pakhtunkhwa. Of 1,872 samples, 1,055 (56.36%) were from female and 817 (43.64%) from male participants. Humans sampled in this study were divided into 6 age groups: 15-24 years (n = 438), 25-34 years (n = 730), 35-44 years (n = 388), 45-54 years (n = 226), 55-64 years (n = 70) and >65 years (n = 20). Mean age of the sampled population was 33.36 years.
Animal and Tick Samples
For animal sampling, we selected 14 districts from Punjab, 3 from Khyber Pakhtunkhwa, 7 from Balochistan, and 5 from Sindh. We chose sampling sites on the basis of animal populations, ease of sampling, and the presence of veterinary clinics. We sampled a total of 311 buffaloes, 480 camels, 183 cattle, 440 goats, and 424 sheep; from each animal, we drew ≈4 mL blood aseptically directly into the gel-clot activator containing vacutainer (Improvacuter). We centrifuged samples, and then harvested serum samples and stored them at −40°C. The animal sampling period spanned 30 months during 2015-2018. In addition, Punjab Livestock and Dairy Development Department provided 98 plasma samples (24 from goats, 28 from buffaloes, and 46 from cows) from the household livestock of the CCHF-suspected human case-patients.
We collected a total of 509 Hyalomma spp., 134 Rhipicephalus spp., 77 Haemaphysalis spp., and 54 Rhipicephalus spp. ticks from livestock from Punjab province of Pakistan. The ticks were collected at the time of field sampling. Animals randomly selected for serum collection were also carefully examined for the presence of ticks; if infested, we collected the ticks by removing them with forceps from the animals. We stored ticks at 4°C in the field and sent them to University of Agriculture Faisalabad, Pakistan, where they were stored at −40°C.
Serologic Testing
For human serum samples, we used a 2-step approach. In the first step, we screened all human serum samples using a commercial ELISA (Vector-Best, https://vector-best.ru) according to the manufacturer's instructions. In the second step, all ELISA-positive serum samples were confirmed by indirect immunofluorescence assay. The cells were fixed with phosphate-buffered saline (PBS, pH = 7.5) containing 4% paraformaldehyde, permeablised with 0.2% TritonX-100, and blocked with 5% bovine serum albumin at 37°C for 1 hour. We added serum samples diluted in 1% bovine serum albumin and incubated plates overnight at 4°C. We washed the culture plates and added FITC-tagged anti-human IgG at a dilution of 1:1,000 (Sigma, USA). We incubated plates for 1 hour, then washed them and added 100 μL of 1× PBS solution. We observed fluorescence using a fluorescence microscope and acquired images. We first tested serum samples at a dilution of 1:100; negative samples were further tested at a dilution of 1:20.
We used anti-CCHFV NP monoclonal antibody (43E5) as the positive control.
For animal serum samples, we conducted screening of anti-CCHFV IgGs by ELISA (ID Vet, https://www.id-vet.com). This double antigen multi-species ELISA can detect IgG antibodies against NP protein of CCHFV in caprine, ovine, bovine, and other susceptible species' serum samples.
We used animal plasma samples and ticks to screen CCHFV antigen by VectoCrimea-CHF-antigen (Vector-Best, https://vector-best.ru) ELISA kit according to the manufacturer's instructions.
Reverse Transcription PCR (RT-PCR)
We extracted total RNA from CCHFV antigen-positive samples using TRIzol reagent (Invitrogen, https://www.thermofisher.com) and performed RT-PCR as previously described (2).
We visualized the PCR product on 0.8%-1% agarose gel after electrophoresis, then performed Sanger sequencing and edited sequences using Geneious R11. We performed BLAST searches using the nonredundant database (https://blast.ncbi.nlm.nih.gov/Blast.cgi). We performed multiple sequence alignment using MAFFT alignment plugin in Geneious R11 (https://www.geneious.com). We performed phylogenetic analysis in MEGA version 7.0 software (https://www.megasoftware.net).
Whole-Genome Sequencing and Analysis
We prepared libraries for next-generation sequencing using Truseq mRNA kit (TruSeq Stranded mRNA Library Prep Kit, Cat # RS-122-2101; Illumina) following the manufacturer's instructions. We performed sequencing on a HiSeq 3000 sequencer (). We analyzed the data in Metavisitor (a suite of galaxy tools) as described previously (3). We then used the BLAST guided scaffold to reference align the reads in Geneious R11. We set up RT-PCR reaction to fill the gap in L segment by using 3508 F(CCHF-L): GGCCAGCTTATCACTCATGGA and 3974 R(CCHF-L): CATTCTGCTGCCACCTCCTT primers.
Statistical Analysis
We conducted statistical analysis using R version 3.5.1 (https://www.r-project.org). We investigated positive samples by χ 2 test for the association of important host (location, sex, and age) risk factors with the occurrence of infection in animals and human populations of Pakistan.
We used the analysis packages Epicalc version 2.15.1.0 and DescTools version 0.99.25. For all analyses, p<0.05 was considered significant.
We built a binary logistic regression model to evaluate the risk factors for the seroprevalence of CCHFV in animals and humans. We entered all the variables with p<0.20 at univariable analysis into the model. We performed backward stepwise removal of the variables with p>0.05 until only significant (p<0.05) variables remained in the model. We assessed the fit of the final model by values of Nagelkerke R Square (NR 2 ) and Hosmer and Lemeshow (HL) goodness-of-fit test (4). 
